Gemini BioProducts Holding, Inc. (GeminiBio), a portfolio company of BelHealth Investment Partners, LLC (BelHealth), announced on Thursday that it has named Gopi Natarajan as its new director.
Natarajan has over thirty-five years of leadership experience in the healthcare industry. He co-Founded Omega Healthcare and held the position of chief executive officer for 18 years.
Harold S. Blue, Managing Partner of BelHealth Investment Partners, said, 'I have known Gopi for over 25 years and our predecessor fund was the first institutional investor in Omega back in 2006 and is now the leading RCM company backed by Goldman Sachs and Everstone Capital. He has stellar leadership and operational skills and will assist the GeminiBio team execute during its imminent growth phase. I am looking forward to working closely with Gopi again.'
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar